News and Events

Are you using the right reagents for Hemophilia testing?

Hemophilia testing is complicated – DiaPharma scientists can help you choose the right assays for your testing needs. We offer a variety of kits and reagents to measure FVIII and FIX. Contact us to learn more.

Factor VIII, IX, vWF, XIII hemophilia measurement assay test kit

COAMATIC® FVIII (K822585)

COATEST® SP FVIII (K824086)

COATEST® SP4 FVIII (K824094)

● Contains bovine FIXa + FX reagents

● FDA-cleared

Technochrom FVIII 2G on Ceveron® s100*

● Automated sensitive FVIII assay

Technoclone Factor FVIII Inhibitor (Bethesda)* – fully automated coming soon!

Ceveron® TGA RB on Ceveron® s100*

● Automated, standardized thrombin generation assay

● Optimized for measurement of bleeding tendency, hemophilia research & development

● Explore thrombin generation assay options on the Ceveron s100

ROX FIX*

● Chromogenic FIX for Hemophilia B research

● Accurate and easy to use

*For research use only in US and Canada. Not for use in diagnostic procedures.

Solutions for Detection of Apoptosis in Oncology Xenograft Models

At DiaPharma, we specialize in biomarker assays designed to advance oncology research. One of the hallmarks of cancer is the evasion of apoptosis by tumor cells—making the detection of cellular death, especially apoptosis, a critical readout in the evaluation of anti-cancer therapies.

Xenograft models are widely used in oncology research to study cancer therapies in vivo. However, methods for evaluating the effect of potential drug candidates on tumor growth—such as volume measurements, imaging, or immunohistochemical staining—are often imprecise, expensive, technically demanding, or require sacrificing the xenograft host.

An alternative is the M30 Apoptosense® ELISA*.

P10011 VLV Peviva M30 Apoptosense ELISA measurement assay detection reagent test kit

What is the M30 Apoptosense® ELISA?

This blood-based biomarker assay utilizes the M30® antibody which specifically detects a caspase-cleaved fragment of cytokeratin 18 (CK18), a cytoskeletal protein expressed in epithelial cells and cleaved by caspases early during apoptosis. The cleaved CK18 fragment (ccK18) is released into the bloodstream, and its concentration in serum or plasma measured with the M30 Apoptosense® ELISA correlates with the extent of epithelial cell apoptosis.

Why choose the M30 Apoptosense® ELISA for use with your xenograft model?

● The M30® antibody is highly specific for human ccK18 and does not cross-react with murine proteins, enabling precise detection of apoptosis of human tumor cells with xenograft models.

● Minimally invasive blood sampling allows for longitudinal assessment of treatment response.

● The assay provides sensitive, quantitative measurements to evaluate dose- and time-dependent effects of potential drug candidates.

● Incorporating the M30® biomarker offers a robust, translational tool to strengthen efficacy assessments — particularly valuable for bridging preclinical findings to clinical applications.

We would be happy to provide more detailed information tailored to your research. Please don’t hesitate to reach out to our Scientists or your local DiaPharma Territory Manager.

*For research use only in US and Canada. Not for use in diagnostic procedures.